+44 (0)20 8762 8008
Change Language
[Close]
- English
  
  Japanese
  
  English
Home
Overview
- Pandemic
- Bird Flu
Subscribers
Locations
Newsroom
- News
- Editorials
- FAQs

Quick Links

COVID-19

Public Access

Interactive COVID-19 Data by Location

COVID-19 Case Count Trackers

Education and Communication

COVID-19 FAQs and External Resources

COVID-19 Videos

Member Access

Travel Restrictions, Flight Operations and Screening

COVID-19 Digital Passports

Scientific Update

COVID-19 FAQs

COVID-19 Vaccine

COVID-19 Vaccine FAQs

COVID-19 Variants

COVID-19 Testing

COVID-19 Treatment

Use of Face Masks by the General Public

COVID-19 Travel Advice

COVID-19 Disease and Prevention Article

Sign up for Emails and Alerts

Premium Services Member Access

COVID-19 Manager Advice

COVID-19 Case Definitions used by different authorities

Pandemic Local Impact Tool

COVID-19 Communication Material

COVID-19 Modelling

COVID-19 Useful Links

…
37
38
39
40
41
…

Study: Fluvoxamine lowers risk of hospitalisation from COVID-19
28 October, 2021
A large randomised clinical trial has found that...
COVID-19
WHO COVID-19 Weekly Reports, October 2021
27 October, 2021
Weekly reports on the global COVID-19 situation from the WHO...
COVID-19
Study finds vaccine safe even with allergies
United States // 27 October, 2021
Most completed the series even with symptoms…
COVID-19
Molnupiravir licensed for free in low-income countries
United States // 27 October, 2021
More than 100 countries to see expanded access…
COVID-19
Vaccinations of children (3-11 years) begins
China // 27 October, 2021
Covid vaccination of 3-11 years begins in some Chinese provinces
COVID-19
EMA recommends Spikevax booster for 18 years and older
27 October, 2021
EMA recommends Moderna's vaccine for 18 years and older
COVID-19
ECDC advice on using COVID-19 rapid antigen tests
27 October, 2021
Although many of the rapid antigen tests are not as sensitive as standard tests, they can be used in ways that recognise this issue....
COVID-19
WHO emergency committee meetings on the COVID-19 pandemic
26 October, 2021
The pandemic remains a PHEIC...
COVID-19
EMA begins speedy review of new antiviral medication
25 October, 2021
Preliminary evidence is promising…
COVID-19
Vaccine update - adults aged 18 and over are now eligible
Botswana // 25 October, 2021
Botswana has expanded its vaccination campaign...
COVID-19
Hubei Province to vaccinate children
China // 25 October, 2021
Children aged 3-11 years will be eligible…
COVID-19
Study: COVID-19 likely to be a seasonal infection
22 October, 2021
Evidence suggests that COVID-19 could be a seasonal infection...
COVID-19
US regulatory agencies recommend booster vaccination
United States // 21 October, 2021
Booster dose eligibility expanded…
COVID-19
Study: Mild COVID-19 lasts longer in obese and overweight individuals
21 October, 2021
Overweight and obese individuals with mild COVID-19 have higher chances of longer duration of symptoms...
COVID-19
Pfizer-BioNTech COVID-19 vaccine approved for 12 to 15 year olds, study results published
United States // 20 October, 2021
Study results from trials of the Pfizer-BioNTech vaccine in 12 to 15 years show favourable results...
COVID-19
International travel pass launched
Australia // 19 October, 2021
The pass is now available for use...
COVID-19
COVID-19 Update – Cases rising in fifth wave
Finland // 18 October, 2021
Finland is experiencing the fifth wave...
COVID-19
ECDC report on improving acceptance of COVID-19 vaccine across EU/EEA countries
15 October, 2021
Based on a "5Cs" model...
COVID-19
WHO Assessment - Only one in seven COVID-19 cases detected in Africa
14 October, 2021
WHO AFRO announced a new initiative to improve COVID-19 detection in Africa...
COVID-19
The role of face coverings in transmission of COVID-19, Public Health England
14 October, 2021
Statement from Public Health England's Respiratory Evidence Panel...
COVID-19

…
37
38
39
40
41
…

Additional data provided by

© 2024 International SOS